Annual EBIT
$132.45 M
-$131.04 M-49.73%
December 31, 2023
Summary
- As of February 7, 2025, IART annual earnings before interest & taxes is $132.45 million, with the most recent change of -$131.04 million (-49.73%) on December 31, 2023.
- During the last 3 years, IART annual EBIT has fallen by -$32.66 million (-19.78%).
- IART annual EBIT is now -50.03% below its all-time high of $265.07 million, reached on December 31, 2021.
Performance
IART EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$989.00 K
-$4.46 M-128.53%
September 30, 2024
Summary
- As of February 7, 2025, IART quarterly earnings before interest & taxes is -$989.00 thousand, with the most recent change of -$4.46 million (-128.53%) on September 30, 2024.
- Over the past year, IART quarterly EBIT has dropped by -$32.66 million (-103.12%).
- IART quarterly EBIT is now -101.23% below its all-time high of $80.21 million, reached on March 31, 2021.
Performance
IART Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$53.48 M
-$32.66 M-37.92%
September 30, 2024
Summary
- As of February 7, 2025, IART TTM earnings before interest & taxes is $53.48 million, with the most recent change of -$32.66 million (-37.92%) on September 30, 2024.
- Over the past year, IART TTM EBIT has dropped by -$113.46 million (-67.96%).
- IART TTM EBIT is now -79.82% below its all-time high of $265.07 million, reached on December 31, 2021.
Performance
IART TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IART EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.7% | -103.1% | -68.0% |
| 3 y3 years | -19.8% | -103.1% | -68.0% |
| 5 y5 years | +8.5% | -103.1% | -68.0% |
IART EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.0% | at low | -101.3% | at low | -79.8% | at low |
| 5 y | 5-year | -50.0% | +16.1% | -101.2% | at low | -79.8% | at low |
| alltime | all time | -50.0% | +797.1% | -101.2% | +96.8% | -79.8% | +342.0% |
Integra LifeSciences Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$989.00 K(-128.5%) | $53.48 M(-37.9%) |
| Jun 2024 | - | $3.47 M(-58.7%) | $86.14 M(-13.0%) |
| Mar 2024 | - | $8.39 M(-80.3%) | $98.96 M(-25.3%) |
| Dec 2023 | $132.45 M(-49.7%) | $42.61 M(+34.5%) | $132.45 M(-20.7%) |
| Sep 2023 | - | $31.67 M(+94.4%) | $166.94 M(-19.3%) |
| Jun 2023 | - | $16.29 M(-61.1%) | $206.87 M(-18.7%) |
| Mar 2023 | - | $41.88 M(-45.7%) | $254.40 M(-3.5%) |
| Dec 2022 | $263.49 M(-0.6%) | $77.10 M(+7.7%) | $263.49 M(+5.3%) |
| Sep 2022 | - | $71.61 M(+12.2%) | $250.30 M(+3.6%) |
| Jun 2022 | - | $63.81 M(+25.2%) | $241.67 M(+2.5%) |
| Mar 2022 | - | $50.97 M(-20.2%) | $235.84 M(-11.0%) |
| Dec 2021 | $265.07 M(+60.6%) | $63.91 M(+1.5%) | $265.07 M(+3.0%) |
| Sep 2021 | - | $62.98 M(+8.6%) | $257.43 M(+0.3%) |
| Jun 2021 | - | $57.97 M(-27.7%) | $256.75 M(+18.8%) |
| Mar 2021 | - | $80.21 M(+42.5%) | $216.11 M(+30.9%) |
| Dec 2020 | $165.10 M(+44.7%) | $56.27 M(-9.7%) | $165.10 M(+11.0%) |
| Sep 2020 | - | $62.31 M(+259.5%) | $148.70 M(+104.1%) |
| Jun 2020 | - | $17.33 M(-40.6%) | $72.85 M(-30.8%) |
| Mar 2020 | - | $29.19 M(-26.8%) | $105.28 M(-7.7%) |
| Dec 2019 | $114.06 M(-6.6%) | $39.87 M(-394.3%) | $114.06 M(+1.3%) |
| Sep 2019 | - | -$13.55 M(-127.2%) | $112.64 M(-25.7%) |
| Jun 2019 | - | $49.77 M(+31.1%) | $151.69 M(+14.8%) |
| Mar 2019 | - | $37.97 M(-1.2%) | $132.16 M(+8.2%) |
| Dec 2018 | $122.09 M(+163.1%) | $38.45 M(+50.8%) | $122.09 M(+27.2%) |
| Sep 2018 | - | $25.50 M(-15.7%) | $95.99 M(+19.3%) |
| Jun 2018 | - | $30.23 M(+8.4%) | $80.48 M(+24.9%) |
| Mar 2018 | - | $27.90 M(+125.9%) | $64.43 M(+38.8%) |
| Dec 2017 | $46.40 M(-60.1%) | $12.35 M(+23.5%) | $46.40 M(-39.0%) |
| Sep 2017 | - | $10.00 M(-29.5%) | $76.08 M(-21.9%) |
| Jun 2017 | - | $14.18 M(+43.6%) | $97.37 M(-7.0%) |
| Mar 2017 | - | $9.88 M(-76.5%) | $104.72 M(-9.9%) |
| Dec 2016 | $116.21 M(+38.0%) | $42.02 M(+34.3%) | $116.21 M(+16.4%) |
| Sep 2016 | - | $31.29 M(+45.3%) | $99.81 M(+24.2%) |
| Jun 2016 | - | $21.53 M(+0.8%) | $80.35 M(-2.4%) |
| Mar 2016 | - | $21.37 M(-16.6%) | $82.31 M(-2.2%) |
| Dec 2015 | $84.20 M(+24.7%) | $25.62 M(+116.7%) | $84.20 M(-3.8%) |
| Sep 2015 | - | $11.83 M(-49.7%) | $87.49 M(-5.4%) |
| Jun 2015 | - | $23.49 M(+1.0%) | $92.54 M(+13.4%) |
| Mar 2015 | - | $23.26 M(-19.5%) | $81.61 M(+21.0%) |
| Dec 2014 | $67.53 M(+75.4%) | $28.91 M(+71.4%) | $67.47 M(-36.3%) |
| Sep 2014 | - | $16.87 M(+34.2%) | $105.99 M(+83.5%) |
| Jun 2014 | - | $12.57 M(+37.9%) | $57.76 M(+13.9%) |
| Mar 2014 | - | $9.12 M(-86.5%) | $50.73 M(+31.7%) |
| Dec 2013 | $38.51 M(-48.1%) | $67.44 M(-315.0%) | $38.51 M(-461.2%) |
| Sep 2013 | - | -$31.37 M(-666.4%) | -$10.66 M(-126.3%) |
| Jun 2013 | - | $5.54 M(-278.6%) | $40.51 M(-24.5%) |
| Mar 2013 | - | -$3.10 M(-117.0%) | $53.64 M(-27.8%) |
| Dec 2012 | $74.27 M(+32.3%) | $18.27 M(-7.8%) | $74.27 M(+15.6%) |
| Sep 2012 | - | $19.80 M(+6.1%) | $64.24 M(+1.5%) |
| Jun 2012 | - | $18.67 M(+6.6%) | $63.31 M(+18.7%) |
| Mar 2012 | - | $17.52 M(+112.7%) | $53.35 M(-5.0%) |
| Dec 2011 | $56.13 M(-44.1%) | $8.24 M(-56.4%) | $56.13 M(-22.5%) |
| Sep 2011 | - | $18.87 M(+116.4%) | $72.46 M(-9.7%) |
| Jun 2011 | - | $8.72 M(-57.0%) | $80.25 M(-17.2%) |
| Mar 2011 | - | $20.30 M(-17.4%) | $96.92 M(-3.5%) |
| Dec 2010 | $100.47 M(+4.2%) | $24.57 M(-7.9%) | $100.47 M(-2.9%) |
| Sep 2010 | - | $26.66 M(+5.0%) | $103.46 M(+3.0%) |
| Jun 2010 | - | $25.39 M(+6.5%) | $100.43 M(+1.9%) |
| Mar 2010 | - | $23.85 M(-13.4%) | $98.60 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $96.38 M(+98.2%) | $27.55 M(+16.6%) | $96.38 M(+1.4%) |
| Sep 2009 | - | $23.64 M(+0.3%) | $95.00 M(+96.0%) |
| Jun 2009 | - | $23.56 M(+8.9%) | $48.48 M(-2.5%) |
| Mar 2009 | - | $21.63 M(-17.4%) | $49.72 M(+2.3%) |
| Dec 2008 | $48.62 M(-27.7%) | $26.18 M(-214.4%) | $48.62 M(+28.0%) |
| Sep 2008 | - | -$22.89 M(-192.3%) | $38.00 M(-52.0%) |
| Jun 2008 | - | $24.80 M(+20.8%) | $79.22 M(+11.1%) |
| Mar 2008 | - | $20.54 M(+32.0%) | $71.32 M(+6.0%) |
| Dec 2007 | $67.29 M(+14.5%) | $15.55 M(-15.2%) | $67.29 M(-6.4%) |
| Sep 2007 | - | $18.34 M(+8.5%) | $71.88 M(+10.0%) |
| Jun 2007 | - | $16.89 M(+2.4%) | $65.36 M(+6.1%) |
| Mar 2007 | - | $16.50 M(-18.1%) | $61.62 M(+4.9%) |
| Dec 2006 | $58.74 M(+4.7%) | $20.15 M(+70.5%) | $58.74 M(+9.8%) |
| Sep 2006 | - | $11.81 M(-10.2%) | $53.51 M(-7.4%) |
| Jun 2006 | - | $13.16 M(-3.4%) | $57.79 M(+1.8%) |
| Mar 2006 | - | $13.62 M(-8.6%) | $56.77 M(+1.2%) |
| Dec 2005 | $56.10 M(+126.4%) | $14.91 M(-7.3%) | $56.10 M(+2.3%) |
| Sep 2005 | - | $16.09 M(+32.5%) | $54.82 M(+106.5%) |
| Jun 2005 | - | $12.14 M(-6.3%) | $26.55 M(+2.1%) |
| Mar 2005 | - | $12.96 M(-5.0%) | $26.01 M(+5.0%) |
| Dec 2004 | $24.78 M(-37.5%) | $13.63 M(-211.9%) | $24.78 M(+2.6%) |
| Sep 2004 | - | -$12.18 M(-205.0%) | $24.14 M(-48.9%) |
| Jun 2004 | - | $11.60 M(-1.1%) | $47.25 M(+7.5%) |
| Mar 2004 | - | $11.73 M(-9.7%) | $43.94 M(+10.8%) |
| Dec 2003 | $39.65 M(+84.3%) | $13.00 M(+19.0%) | $39.65 M(+18.6%) |
| Sep 2003 | - | $10.92 M(+31.8%) | $33.44 M(+26.5%) |
| Jun 2003 | - | $8.29 M(+11.4%) | $26.43 M(+11.8%) |
| Mar 2003 | - | $7.44 M(+9.6%) | $23.63 M(+9.8%) |
| Dec 2002 | $21.52 M(+50.6%) | $6.79 M(+73.4%) | $21.52 M(+10.7%) |
| Sep 2002 | - | $3.91 M(-28.7%) | $19.44 M(+0.9%) |
| Jun 2002 | - | $5.49 M(+3.1%) | $19.26 M(+11.8%) |
| Mar 2002 | - | $5.33 M(+13.0%) | $17.23 M(+9.6%) |
| Dec 2001 | $14.29 M(-177.7%) | $4.71 M(+26.1%) | $15.72 M(-755.7%) |
| Sep 2001 | - | $3.74 M(+8.1%) | -$2.40 M(-65.0%) |
| Jun 2001 | - | $3.46 M(-9.4%) | -$6.85 M(-37.1%) |
| Mar 2001 | - | $3.81 M(-128.5%) | -$10.89 M(-26.6%) |
| Dec 2000 | -$18.38 M(+20.9%) | -$13.40 M(+1779.7%) | -$14.84 M(+167.4%) |
| Sep 2000 | - | -$713.00 K(+21.3%) | -$5.55 M(-26.4%) |
| Jun 2000 | - | -$588.00 K(+320.0%) | -$7.54 M(-35.8%) |
| Mar 2000 | - | -$140.00 K(-96.6%) | -$11.75 M(-22.2%) |
| Dec 1999 | -$15.21 M(-13.4%) | -$4.11 M(+52.2%) | -$15.11 M(-14.4%) |
| Sep 1999 | - | -$2.70 M(-43.8%) | -$17.66 M(-2.8%) |
| Jun 1999 | - | -$4.80 M(+37.1%) | -$18.16 M(+3.4%) |
| Mar 1999 | - | -$3.50 M(-47.4%) | -$17.56 M(-0.6%) |
| Dec 1998 | -$17.56 M(-7.6%) | -$6.66 M(+108.1%) | -$17.66 M(-20.1%) |
| Sep 1998 | - | -$3.20 M(-23.8%) | -$22.10 M(+1.4%) |
| Jun 1998 | - | -$4.20 M(+16.7%) | -$21.80 M(+7.9%) |
| Mar 1998 | - | -$3.60 M(-67.6%) | -$20.20 M(+6.9%) |
| Dec 1997 | -$19.00 M(+100.0%) | -$11.10 M(+282.8%) | -$18.90 M(+81.7%) |
| Sep 1997 | - | -$2.90 M(+11.5%) | -$10.40 M(+3.0%) |
| Jun 1997 | - | -$2.60 M(+13.0%) | -$10.10 M(+5.2%) |
| Mar 1997 | - | -$2.30 M(-11.5%) | -$9.60 M(+4.3%) |
| Dec 1996 | -$9.50 M(+58.3%) | -$2.60 M(0.0%) | -$9.20 M(+3.4%) |
| Sep 1996 | - | -$2.60 M(+23.8%) | -$8.90 M(+15.6%) |
| Jun 1996 | - | -$2.10 M(+10.5%) | -$7.70 M(+133.3%) |
| Mar 1996 | - | -$1.90 M(-17.4%) | -$3.30 M(-466.7%) |
| Dec 1995 | -$6.00 M | -$2.30 M(+64.3%) | $900.00 K(-71.9%) |
| Sep 1995 | - | -$1.40 M(-160.9%) | $3.20 M(-30.4%) |
| Jun 1995 | - | $2.30 M(0.0%) | $4.60 M(+100.0%) |
| Mar 1995 | - | $2.30 M | $2.30 M |
FAQ
- What is Integra LifeSciences Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual EBIT year-on-year change?
- What is Integra LifeSciences Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly EBIT year-on-year change?
- What is Integra LifeSciences Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings TTM EBIT year-on-year change?
What is Integra LifeSciences Holdings annual earnings before interest & taxes?
The current annual EBIT of IART is $132.45 M
What is the all time high annual EBIT for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual earnings before interest & taxes is $265.07 M
What is Integra LifeSciences Holdings annual EBIT year-on-year change?
Over the past year, IART annual earnings before interest & taxes has changed by -$131.04 M (-49.73%)
What is Integra LifeSciences Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of IART is -$989.00 K
What is the all time high quarterly EBIT for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly earnings before interest & taxes is $80.21 M
What is Integra LifeSciences Holdings quarterly EBIT year-on-year change?
Over the past year, IART quarterly earnings before interest & taxes has changed by -$32.66 M (-103.12%)
What is Integra LifeSciences Holdings TTM earnings before interest & taxes?
The current TTM EBIT of IART is $53.48 M
What is the all time high TTM EBIT for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high TTM earnings before interest & taxes is $265.07 M
What is Integra LifeSciences Holdings TTM EBIT year-on-year change?
Over the past year, IART TTM earnings before interest & taxes has changed by -$113.46 M (-67.96%)